2024 – Year of Research Impact

From left to right: Dave Tidman, patient advocate; Andrew Craig, Director, Sinclair Cancer Research Institute; Jane Philpott, former Dean, Queen’s Health Sciences; Murray Sinclair, alumnus and donor; Annette Hay, Senior Investigator, Canadian Cancer Trials Group; Cara Sinclair; Cathy Tidman, patient advocate; Patrick Deane, Principal and Vice-Chancellor; Paul Kubes, Canada Excellence Research Chair in Immunophysiology and Immunotherapy.

Leave a Reply

Your email address will not be published. Required fields are marked *